FDA Adverse Event Malfunction Summary report: N

ARCHITECT I1000SR ANALYZER

MDR report key: 9039099 · Received September 13, 2019

Report

Report Number
1628664-2019-00611
Event Type
Malfunction
Date Received
September 13, 2019
Report Date
September 23, 2019
Manufacturer
ABBOTT MANUFACTURING INC
Product Code
JJE
UDI-DI
00380740001537
PMA / PMN Number
EXEMPT
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
NL
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 0

FURTHER INVESTIGATION OF THE CUSTOMER ISSUE INCLUDED A REVIEW OF THE COMPLAINT TEXT, A SEARCH FOR SIMILAR COMPLAINTS, REVIEW OF INSTRUMENT LOGS, A REVIEW OF LABELING AND INSTRUMENT SERVICE. NO ADVERSE TREND WAS IDENTIFIED FOR THE CUSTOMER'S ISSUE. LABELING WAS REVIEWED AND FOUND TO BE ADEQUATE. THE ISSUE WAS RESOLVED BY REPLACING THE VALVE, BYPASS, 2 WAY (ROHS) (PN 7-200607-01). BASED ON ALL AVAILABLE INFORMATION AND ABBOTT DIAGNOSTICS' COMPLAINT INVESTIGATION NO PRODUCT DEFICIENCY WAS IDENTIFIED.

Additional Manufacturer Narrative · 1

ALL AVAILABLE PATIENT INFORMATION WAS INCLUDED. ADDITIONAL PATIENT DETAILS ARE NOT AVAILABLE. AN EVALUATION IS IN PROCESS. A FINAL REPORT WILL BE SUBMITTED WHEN THE EVALUATION IS COMPLETE.

Description of Event or Problem · 1

THE CUSTOMER OBSERVED A FALSE NEGATIVE TROPONIN RESULT ON THE ARCHITECT I1000SR ANALYZER. THE FOLLOWING INFORMATION WAS PROVIDED: ON (B)(6) 2019: PATIENT WAS BROUGHT IN TO EHS. TROPONIN RESULT WAS 0 NG/L. PATIENT WAS SENT HOME AS THE CUSTOMER USES A CUTOFF OF 2.9 NG/L. ON (B)(6) 2019: PATIENT WAS BACK AT THE HOSPITAL. TROPONIN WAS MEASURED AND THE RESULTS IS 6000 NG/L. SAMPLE FROM (B)(6) WAS REANALYZED AND THE RESULT IS 1400 NG/L. NO FURTHER PATIENT INFORMATION OR DETAILS ON IMPACT WERE AVAILABLE. NO NEGATIVE IMPACT TO PATIENT MANAGEMENT IS KNOWN.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
812322 ARCHITECT I1000SR ANALYZER AUTOMATED IMMUNOASSAY ANALYZER JJE ABBOTT MANUFACTURING INC 00380740001537

Patients

Seq Age Sex Outcome Treatment
1